Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles

Clinical trial NCT00324298 · COMPLETED

Trial details

NCT number: NCT00324298
Sponsor: Queen Mary University of London
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Drug/Agent Toxicity by Tissue/Organ Testicular Germ Cell Tumor

Start date: 2003-07-01
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.